HomeNewsBusinessMarketsGrab pharma picks for healthy run, say analysts

Grab pharma picks for healthy run, say analysts

Investing in shares of pharma companies is likely to give good returns in mid-to-long term, analysts say. The markets have been volatile off late, but analysts say pharma sector will outperform as several companies will get a booster shot from lot of top-selling drugs going off-patent in the US.

June 27, 2011 / 15:55 IST

Story continues below Advertisement

Nachiket Kelkar
Moneycontrol.com

Investing in shares of pharma companies is likely to give good returns in mid-to-long term, analysts say. The markets have been volatile off late, but analysts say pharma sector will outperform as several companies will get a booster shot from lot of top-selling drugs going off-patent in the US. The pharma sector has outperformed the broader markets this year. The NSE

first published: Jun 27, 2011 11:29 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Grab pharma picks for healthy run, say analysts

Investing in shares of pharma companies is likely to give good returns in mid-to-long term, analysts say. The markets have been volatile off late, but analysts say pharma sector will outperform as several companies will get a booster shot from lot of top-selling drugs going off-patent in the US.

News

Features

Tools

Specials

Network 18 Sites

Personal Finance

Quick Links